簡要描述:MOGAT2蛋白抗體免 疫 原;KLH conjugated synthetic peptide derived from human MOGAT2: 51-150/334
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
MOGAT2蛋白抗體
產(chǎn)品名稱 | 英文名稱 | 貨號 |
MOGAT2蛋白抗體 | MOGAT2 | GOY-01K2585 |
商品屬性:
英文名稱: MOGAT2
中文名:MOGAT2蛋白抗體
別 名;2 acylglycerol O
acyltransferase 2; 2-acylglycerol O-acyltransferase 2; Acyl
CoA:monoacylglycerol acyltransferase 2; Acyl-CoA:monoacylglycerol
acyltransferase 2; DC5; DGAT2L5; Diacylglycerol acyltransferase 2 like protein
5; Diacylglycerol acyltransferase 2-like protein 5; Diacylglycerol O
acyltransferase candidate 5; Diacylglycerol O-acyltransferase candidate 5; EC
2.3.1.22; FLJ22644; hDC5; hMGAT2; Mgat1l; MGAT2; MGC119183; MGC119184;
MGC119185; MGC189143; mogat2; MOGT2_HUMAN; Monoacylglycerol O acyltransferase 1
like; Monoacylglycerol O acyltransferase 2; Monoacylglycerol O-acyltransferase
2.
研究領(lǐng)域;腫瘤 細(xì)胞生物 信號轉(zhuǎn)導(dǎo) 新陳代謝
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, )
產(chǎn)品應(yīng)用;ELISA=1:5000-10000
IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;38kDa
細(xì)胞定位;細(xì)胞漿
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human MOGAT2: 51-150/334
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項;This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
Dietary fat absorption from the small intestine is
facilitated by acyl-CoA:monoacylglycerol transferase (MOGAT; EC 2.3.1.22) and
acyl-CoA:diacylglycerol acyltransferase (DGAT; see MIM 604900) activities.
MOGAT catalyzes the joining of monoacylglycerol and fatty acyl-CoAs to form
diacylglycerol (Yen and Farese, 2003 [PubMed 12621063]).[supplied by OMIM,
Mar 2008] Catalyzes the formation of diacylglycerol from
2-monoacylglycerol and fatty acyl-CoA. Has a preference toward monoacylglycerols
containing unsaturated fatty acids in an order of C18:3 > C18:2 > C18:1
> C18:0. Plays a central role in absorption of dietary fat in the small
intestine by catalyzing the resynthesis of triacylglycerol in enterocytes.
May play a role in diet-induced obesity. |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測結(jié)果是陽性。技術(shù)服務(wù)實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項目實際需求情況靈活選擇進行,我公司將為您的項目提供專業(yè)的建議。在制備過程中,與客戶互動驗證,確保最終制備的抗體ELISA陽性血清檢測達(dá)到合同要求的同時,也能滿足客戶抗體最終應(yīng)用驗證需求。技術(shù)服務(wù)實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達(dá)等先進平臺,能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項免疫學(xué)及檢測服務(wù):
我公司也為客戶提供單項免疫學(xué)和檢測服務(wù),如動物免疫、動物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測服務(wù)。
抗體定制服務(wù):
已注冊商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對有特定應(yīng)用要求和各種模型測試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃